These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15773282)

  • 21. Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.
    Menjoge AR; Kulkarni MG
    Biomacromolecules; 2007 Jan; 8(1):240-51. PubMed ID: 17206813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole--a new formulation.
    Armstrong D
    Can J Gastroenterol; 1997; 11(8):655-6. PubMed ID: 9459043
    [No Abstract]   [Full Text] [Related]  

  • 23. Minimization of Acid-Catalyzed Degradation in KinetiSol Processing through HPMCAS Neutralization.
    Corum I; Spangenberg A; Miller K; Kucera S; Miller D
    Mol Pharm; 2023 Mar; 20(3):1599-1612. PubMed ID: 36787489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of cellulose derivatives as novel enteric coating agents soluble at pH 3.5-4.5 and higher.
    Kokubo H; Obara S; Minemura K; Tanaka T
    Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1350-3. PubMed ID: 9301034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the static mercury drop electrode (SMDE).
    Qaisi AM; Tutunji MF; Tutunji LF
    J Pharm Sci; 2006 Feb; 95(2):384-91. PubMed ID: 16380990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of sulfobutylether-beta-cyclodextrin on the stability of S- and R- omeprazole.
    Agatonovic-Kustrin S; Williams D; Ibrahim N; Glass BD
    Curr Drug Discov Technol; 2007 Oct; 4(3):192-7. PubMed ID: 17986001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of derivative spectrophotometric and liquid chromatographic methods for the determination of omeprazole in aqueous solutions during stability studies.
    Castro D; Moreno MA; Torrado S; Lastres JL
    J Pharm Biomed Anal; 1999 Nov; 21(2):291-8. PubMed ID: 10703983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encapsulation of lipophilic drugs within enteric microparticles by a novel coacervation method.
    Dong W; Bodmeier R
    Int J Pharm; 2006 Dec; 326(1-2):128-38. PubMed ID: 16942845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.
    Wegiel LA; Mosquera-Giraldo LI; Mauer LJ; Edgar KJ; Taylor LS
    Pharm Res; 2015 Oct; 32(10):3324-37. PubMed ID: 25975588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing Solvent Exchange-Induced In Situ Forming Gel from Aqueous Insoluble Polymers as Matrix Base for Periodontitis Treatment.
    Srichan T; Phaechamud T
    AAPS PharmSciTech; 2017 Jan; 18(1):194-201. PubMed ID: 26951505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets.
    Bruce LD; Koleng JJ; McGinity JW
    Drug Dev Ind Pharm; 2003 Sep; 29(8):909-24. PubMed ID: 14570312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
    Erah PO; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    J Antimicrob Chemother; 1997 Jan; 39(1):5-12. PubMed ID: 9044021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt.
    El-Sayed A; Boraie NA; Ismail FA; El-Khordagui LK; Khalil SA
    East Mediterr Health J; 2007; 13(6):1427-37. PubMed ID: 18341192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H; Yoshida H; Izutsu K; Goda Y
    J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Polymers on the Physical and Chemical Stability of Spray-dried Amorphous Solid Dispersion: Dipyridamole Degradation Induced by Enteric Polymers.
    Peng T; She Y; Zhu C; Shi Y; Huang Y; Niu B; Bai X; Pan X; Wu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2620-2628. PubMed ID: 29916195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration].
    Navarro MA; Raei N; Torres F; Granero L; García-Zaragoza E; Esplugues JV; Esteban Peris J
    Gastroenterol Hepatol; 1998 Feb; 21(2):63-70. PubMed ID: 9549180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.